Hantech Bio-Technology Co., Ltd. (TPEX:1294)

Market Cap	2.47B -0.3%
Revenue (ttm)	778.54M +4.0%
Net Income	139.05M -10.7%
EPS	4.54 -14.7%
Shares Out	30.23M
PE Ratio	17.97
Forward PE	n/a
Dividend	2.91 (3.58%)
Ex-Dividend Date	Jul 15, 2025

Volume	49,435
Average Volume	154,588
Open	82.20
Previous Close	81.60
Day's Range	81.10 - 82.80
52-Week Range	63.68 - 95.30
Beta	-0.44
RSI	46.24
Earnings Date	Mar 30, 2026

About Hantech Bio-Technology

Hantech Bio-Technology Co., Ltd., through its subsidiaries, engages in the manufacture, trade in, and distributes biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products in Taiwan and internationally. The company offers OEM & ODM manufacturer of liquid, jelly, and gel-type health supplements. It also provides aluminum foil bag designs; and aluminum foil-packaged beverage production activities. In addition, the company is involved in the manufacture of machinery and equipment; and trade in of health food raw ma...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2007
• Employees: 152
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1294

Financial Performance

In 2025, Hantech Bio-Technology's revenue was 778.54 million, an increase of 4.02% compared to the previous year's 748.42 million. Earnings were 139.05 million, a decrease of -10.68%.